close

Enter

Log in using OpenID

Atopic Dermatitis Drug Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025

embed
Atopic dermatitis, also known as eczema, is a condition in which skin becomes dry, itchy, and inflamed, which leads to redness, swelling, scaling, and crusting. Atopic dermatitis is commonly found in children under one year. The exact cause of atop
ATOPIC DERMATITIS DRUG
MARKET
Global Industry Insights, Trends, Outlook, and
Opportunity Analysis, 2017-2025
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Atopic Dermatitis Drug Market Overview
Atopic dermatitis, also known as eczema, is a condition in which skin becomes dry, itchy, and
inflamed, which leads to redness, swelling, scaling, and crusting. Atopic dermatitis is commonly
found in children under one year. The exact cause of atopic dermatitis is undiscovered, but it is
believed that it includes genetics, environmental exposure, immune system dysfunction, and
problem with skin permeability. Dry climate is also a major cause of atopic dermatitis. This
disease is non-contagious and easily diagnosed with signs and symptoms such as swelling and
redness of skin. Many people with atopic dermatitis develop asthma and hay fever. Atopic
dermatitis treatment involves photo therapy, steroid pills, calcineurin inhibitors ointment,
biologic agents such as immunologic, monoclonal antibody, and dietary changes in case of food
allergy.
Request Sample Copy of the Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/712
Atopic Dermatitis Drug Market Taxonomy
By End User;
Hospitals
Clinics
Research Labs
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
By Route of Administration;
• Injectable
• Oral
• Topical
By Therapy;
• Photo Therapy
• Directed Therapy
Topical steroids and development of new drugs fuel the atopic dermatitis drug market
Atopic dermatitis treatment majorly relies on topical steroids and hence the segment holds the largest market
share. A lukewarm bath followed by the application of moisturizer helps in the treatment of atopic dermatitis.
Immunomodulators and pimecrolimus are also used for the treatment of atopic dermatitis. According to the
American Academy of Dermatology, in 2016, there were around 28 million people of all age groups affected by
atopic dermatitis in the U.S. The expected launch of dupilumab, monoclonal antibody developed by Sanofi and
Regeneron Pharmaceuticals Inc. in 2017, which is approved by FDA for the treatment of atopic dermatitis plays
a major role in the treatment of the disease and supports the growth of atopic dermatitis drug market. In
December 2016, the crisaborole ointment was approved by FDA for the treatment of mild atopic dermatitis.
When such drugs are launched, FDA issues black box warning on the label of prescribed drug to warn users
about the side effects. It is expected that new product launches in near future will significantly boost the atopic
dermatitis drug market.
Request a Customization:
https://www.coherentmarketinsights.com/insight/request-customization/712
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Developed regions support the growth of atopic dermatitis drug market
On the basis of geography, the global atopic dermatitis drug market is segmented into North
America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates
the atopic dermatitis drug market due to increasing number of atopic dermatitis cases and high
R&D investment for the development of atopic dermatitis drug. The increase in food and skin
allergies raised the atopic dermatitis cases in infants, which in turn fuels the atopic dermatitis
drug market growth. Europe is the second largest market for atopic dermatitis drugs followed by
Asia Pacific. Asia Pacific is a flourishing market owing to the prevalence of atopic dermatitis and
increased demand for drugs in emerging countries such as India and China. The market is
expected to expand at a high rate in the near future, supporting the global atopic dermatitis
drug market.
Get Exclusive Discount on this CMI Report:
https://www.coherentmarketinsights.com/insight/request-discount/712
Key Players in the Global Atopic Dermatitis Drug Market
Major players in the market use different strategies such as mergers and acquisitions in order
to acquire high market share and attain a competitive edge. In 2016, Novartis AG acquired
Ziarco, which adds oral atopic dermatitis drug to its product pipeline. Pfizer acquired Anacor
Pharmaceuticals in 2016 allowing access to non-steroidal topical gel, crisaborole, approved by
FDA for atopic dermatitis treatment. Some of the key players in the market are Bayer
Healthcare, Valent Pharmaceutical Inc., Astellas Pharma Inc., Meda AB, and Novartis AG.
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization focused on
assisting its plethora of clients achieve transformational growth by helping them make critical business
decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our
client base includes players from across all business verticals in over 150 countries worldwide. We are
uniquely positioned to help businesses around the globe deliver practical and lasting results through
various recommendations about operational improvements, technologies, emerging market trends and
new working methods. We offer both customized and syndicated market research reports that help our
clients create visionary growth plans to provide traction to their business. We meticulously study
emerging trends across various industries at both the global and regional levels to identify new
opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC
STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT CMI
SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
 Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry
 Component Providers and System Integrators
 Private and Government organization
 Distributors, Retailors and Value Added Resellers
 Outsourcing Companies
 Healthcare IT Solutions Developers
 Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY
STUDIES
Insights Published
Per Year
GLOBAL
REPORTS
150+
Consulting Projects
Till Date
COUNTRY
ANALYSIS
CONSULT
PROJECTS
125+
Clients Worldwide
Per Year
110+
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract
Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals,
including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in
order to result in the best possible market research reports across various industries worldwide. Based on our unmatched
expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better
outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure
sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of
opportunities posed therein.
© Coherent market Insights. All Rights Reserved
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702
© Coherent market Insights. All Rights Reserved
1/--pages
Report inappropriate content